Vaxfab Enterprises Approves ₹45 Crore Rights Issue For Existing Shareholders

Board approved rights issue of Rs10 equity shares aggregating up to Rs45 Cr to eligible shareholders on record date to be notified, subject to approvals; approved draft letter of offer. Another dilution-heavy raise after prior rights issue and recent warrant tranches; extends episodic capital pattern amid working-capital strain and recurring audit qualifications. Price, entitlement ratio, record date, use of proceeds and timeline not disclosed; subject to regulatory approvals. Dilution overhang and reconciliation of paid-up capital remain unresolved.